carvedilol and cilnidipine

carvedilol has been researched along with cilnidipine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A	1
Hall, SD; Mohutsky, MA; Posada, MM; Taylor, LS; Tres, F	1

Other Studies

2 other study(ies) available for carvedilol and cilnidipine

Article	Year
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2. Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24 Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity	2012
The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays. Pharmaceutical research, 2019, Oct-25, Volume: 36, Issue:12 Topics: Carvedilol; Colloids; Cytochrome P-450 Enzyme System; Diclofenac; Dihydropyridines; Drug Interactions; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Kinetics; Metabolic Clearance Rate; Microsomes, Liver; Phenacetin; Recombinant Proteins; Solvents; Tamoxifen	2019

Article

Year

Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.

Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012

The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays.

Pharmaceutical research, 2019, Oct-25, Volume: 36, Issue:12

Topics: Carvedilol; Colloids; Cytochrome P-450 Enzyme System; Diclofenac; Dihydropyridines; Drug Interactions; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Kinetics; Metabolic Clearance Rate; Microsomes, Liver; Phenacetin; Recombinant Proteins; Solvents; Tamoxifen

2019